Optison Injection, Solution
Product Images NDC 0407-2707

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Optison (NDC 0407-2707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Optison 01)

FDA Label Image

Principal Display Panel (3 mL Vial Carton Label)

Principal Display Panel (3 mL Vial Carton Label)
This is a description of a medical product called OPTISON, distributed by GE Healthcare, Inc. Each vial contains 3mL of an injectable suspension of microspheres that contain perflutren protein-type A, 10 mg of human USP albumin, N-acetyitryptophan, and caprylc acid in 0.9% aqueous sodium chloride with perflutren gas. The product is used for intravenous use in single-patient use vials, to be discarded after use. The storage temperature range is between 2° to 8°C (36" to 46°F), and it should not be frozen. The product is manufactured by GE Healthcare AS, located in Norway, and it is distributed in the USA. The recommended dosage, preparation, and administration are available on the prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.